Monosaccharides

a-D-Mannose-1-phosphate bis(cyclohexylammonium) salt is a sugar that has the CAS number 51306-17-3 and is listed as a synthetic compound. It is a white to off-white powder that can be used in many different applications, including as an enzyme inhibitor, protein modifier, and prodrug. The modification of this sugar can include fluorination, glycosylation, methylation, or modification with other sugars. This product also has a high purity and custom synthesis.

Mirabegron is a drug that has been used to treat overactive bladder and urinary incontinence. Mirabegron is an agonist of the beta-3 adrenergic receptor and increases the levels of cAMP in cells by binding to this receptor. This leads to relaxation of smooth muscle tissue, which decreases resistance in the bladder and urethra and promotes urine storage. Mirabegron O-glucuronide is a metabolite of mirabegron that can be detected in urine using mass spectrometry methods. Mirabegron O-glucuronide has been found in human liver samples following oral administration, as well as in human blood samples after intravenous administration.

1-O-Tosyl-2,3:4,5-di-O-isopropylidene-L-arabinitol is a sugar that is used in the synthesis of oligosaccharides and complex carbohydrates. This product can be custom synthesized to meet your needs. It has been shown to react with fluorine at high temperatures and with CH3OH/NaOH at low temperatures. 1-O-Tosyl-2,3:4,5-di-O-isopropylidene arabinitol can also be glycosylated or methylated. The CAS number for this product is 1241674-36-1.

6-Deoxy L-glucose is a sugar analogue that inhibits the transport of glucose in bacteria. It competes with glucose for binding to transporter proteins and prevents glucose from being transported into the cell. 6-Deoxy L-glucose has been shown to inhibit the growth of wild-type strains, such as E. coli K12, in a dose-dependent manner. The antibiotic also reduces ATP production by inhibiting enzymes critical for glycolysis and gluconeogenesis. 6-Deoxy L-glucose has an optimum pH of 7.5 and is activated by hydrochloric acid or hydroxyl groups at the gamma position.

Norfluoxetine is a selective serotonin reuptake inhibitor (SSRI) that is metabolized to the active metabolite, norfluoxetine b-D-glucuronide. The metabolism of norfluoxetine b-D-glucuronide has been shown to be inhibited by estradiol. Norfluoxetine b-D-glucuronide also exhibits antioxidant activity, which may be related to its ability to modulate expression of genes encoding antioxidant proteins. Norfluoxetine b-D-glucuronide has been found in wastewater and wastewater treatment plant effluents, suggesting this drug may have an environmental impact. The transcriptome of organisms exposed to norfluoxetine b-D-glucuronide has been studied and it was found that there are some genes that are responsive to this drug.